Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer

Molecular and Cellular Biology

Volumn 32, Issue 11, 2012, Pages 2160-2167

  Grim, Jonathan E ^a,b   Knoblaugh, Sue E ^a   Guthrie, Katherine A ^a   Hagar, Amanda ^a   Swanger, Jherek ^a   Hespelt, Jessica ^a   Delrow, Jeffrey J ^a   Small, Tom ^b   Grady, William M ^a,b   Nakayama, Keiichi I ^c   Clurman, Bruce E ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; FBW7 PROTEIN; MYC PROTEIN; PROTEIN; PROTEIN P53; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ADVANCED CANCER; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; COLORECTAL CANCER; CONTROLLED STUDY; GENE DELETION; HISTOPATHOLOGY; INTESTINE CANCER; INTESTINE EPITHELIUM; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANIMALS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL INSTABILITY; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; F-BOX PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

MURINAE;

EID: 84864000763     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00305-12     Document Type: Article

References (41)

1. Akhoondi S, et al. 2007. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 67:9006-9012.
2. Babaei-Jadidi R, et al. 2011. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation. J. Exp. Med. 208:295-312.
3. Bauer KD, et al. 1993. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 14:486-491.
4. Boivin GP, et al. 2003. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124:762-777.
5. Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM. 1996. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10:1979-1990.
6. Conacci-Sorrell M, Ngouenet C, Eisenman RN. 2010. Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation. Cell 142:480-493.
7. Elyada E, et al. 2011. CKI ablation highlights a critical role for p53 in invasiveness control. Nature 470:409-413.
8. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
9. Grady WM, Markowitz SD. 2002. Genetic and epigenetic alterations in colon cancer. Annu. Rev. Genomics Hum. Genet. 3:101-128.
10. Hinoi T, et al. 2007. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res. 67:9721-9730.
11. Hoeck JD, et al. 2010. Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun. Nat. Neurosci. 13:1365-1372.
12. Hung KE, et al. 2010. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment. Proc. Natl. Acad. Sci. U. S. A. 107:1565-1570.
13. Jonkers J, et al. 2001. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29:418-425.
14. Kemp Z, et al. 2005. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability. Cancer Res. 65:11361-11366.
15. Kwong LN, Dove WF. 2009. APC and its modifiers in colon cancer. Adv. Exp. Med. Biol. 656:85-106.
16. Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
17. Loeb KR, et al. 2005. A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell 8:35-47.
18. Lowe SW, Sherr CJ. 2003. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13:77-83.
19. Madison BB, et al. 2002. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 277:33275-33283.
20. Matsuoka S, et al. 2008. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev. 22:986-991.
21. Maunoury R, et al. 1992. Developmental regulation of villin gene expression in the epithelial cell lineages of mouse digestive and urogenital tracts. Development 115:717-728.
22. Merlos-Suarez A, et al. 2011. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8:511-524.
23. Minella AC, Grim JE, Welcker M, Clurman BE. 2007. p53 and SCFFbw7 cooperatively restrain cyclin E-associated genome instability. Oncogene 26:6948-6953.
24. Minella AC, et al. 2008. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev. 22: 1677-1689.
25. Minella AC, et al. 2002. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr. Biol. 12:1817-1827.
26. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
27. Onoyama I, et al. 2007. Conditional inactivation of Fbxw7 impairs cellcycle exit during T cell differentiation and results in lymphomatogenesis. J. Exp. Med. 204:2875-2888.
28. Rajagopalan H, et al. 2004. Inactivation of hCDC4 can cause chromosomal instability. Nature 428:77-81.
29. Rusan NM, Peifer M. 2008. Original CIN: reviewing roles for APC in chromosome instability. J. Cell Biol. 181:719-726.
30. Sancho R, et al. 2010. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor. Gastroenterology 139:929-941.
31. Shen L, et al. 2007. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc. Natl. Acad. Sci. U. S. A. 104:18654-18659.
32. Sieber OM, Heinimann K, Tomlinson IP. 2003. Genomic instability- the engine of tumorigenesis? Nat. Rev. Cancer 3:701-708.
33. Spruck CH, Won KA, Reed SI. 1999. Deregulated cyclin E induces chromosome instability. Nature 401:297-300.
34. Taketo MM, Edelmann W. 2009. Mouse models of colon cancer. Gastroenterology 136:780-798.
35. Tetzlaff MT, et al. 2004. Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc. Natl. Acad. Sci. U. S. A. 101:3338-3345.
36. Thompson BJ, et al. 2008. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J. Exp. Med. 205:1395-1408.
37. Trobridge P, et al. 2009. TGF-β receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a β-catenin-independent pathway. Gastroenterology 136:1680-1688.e7.
38. Tsunematsu R, et al. 2004. Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. J. Biol. Chem. 279:9417-9423.
39. Walther A, Houlston R, Tomlinson I. 2008. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 57:941-950.
40. Welcker M, Clurman BE. 2008. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 8:83-93.
41. Wood LD, et al. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113.